Singapore HSA registration DE0509406
RANDOX GLUTAMATE DEHYDROGENASE (GLDH)
Device classification
- Device Class
- CLASS B IVD
- Medical Speciality Area
- Clinical chemistry
Registration information
- Registration Number
- DE0509406
- Registration Date
- June 14, 2024
- Retention Due Date
- June 13, 2025
Product description
For the quantitative in vitro determination of Glutamate Dehydrogenase (GLDH) in serum.
Product Owner
- Short Name
- RANDOX LABORATORIES LIMITED
- Address
- 55 Diamond Road, Crumlin, County Antrim, BT29 4QY, UNITED KINGDOM
Registrant
- Address
- 627A ALJUNIED ROAD, BIZTECH CENTRE, #08-09, SINGAPORE 389842
Importer
- Address
- 627A ALJUNIED ROAD, BIZTECH CENTRE, #08-07/09, SINGAPORE 389842
Model information
- Model Name(s)
- GLUTAMATE DEHYDROGENASE (GLDH) GLUTAMATE DEHYDROGENASE (GLDH)
- Model Identifier(s)
- GL441 GL442
About this record
Access comprehensive regulatory information for RANDOX GLUTAMATE DEHYDROGENASE (GLDH) in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0509406 and owned by RANDOX LABORATORIES LIMITED. The device was registered on June 14, 2024.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Free DatabasePowered by Pure Global AIHSA Official DataCLASS B IVD